Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Roger Steiner who wrote (51)	10/19/1997 6:00:00 PM
From: CPAMarty	of 2515

Do you know when myriad is scheduled to start clinical trials? Imclone is scheduled to start Phase III of clinical trial on its cancer treatment in the fourth quarter of this year. I would think that a biotech company like Myriad would stick to cancer research and leave making money on options to the sharks in the trading pits. Stocks will low volume are to easy for the Money Managers (MM's) to manipulate. The MMs usually write the call options, so take a wild guess at who usually wins.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next